Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RBR-547cnx9Recruiting
Single-blind, single-arm trial in decubitus ulcer and cutaneous wound, sponsored by Nipo Serviços Médicos. Primary endpoints: Efficacy of skin regeneration and Safety of Hycos MG500 I. Started May 2024; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on RBR-547cnx9.